SCHEMBL92681

SCHEMBL92681

CCCCCCCCCCn1cc[n+](C)c1

nearest known ligand 0.96

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.96
▸ HSP90AA1 P07900 2/20 0.96
▸ KMT2A Q03164 2/20 0.96
▸ SMN1; SMN2 Q16637 2/20 0.96
▸ APAF1 O14727 1/20 0.96
▸ NPC1 O15118 1/20 0.96
▸ PLA2G1B P04054 1/20 0.96
▸ MAPT P10636 1/20 0.96
▸ MAPK1 P28482 1/20 0.96
▸ HTT P42858 1/20 0.96
▸ RAB9A P51151 1/20 0.96
▸ NPSR1 Q6W5P4 1/20 0.96
▸ ATG4B Q9Y4P1 1/20 0.96
▸ FDPS P14324 16/20 0.44
▸ TBXAS1 P24557 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL899203 1.00 MEN1 (0.96) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL34918 1.00 MEN1 (0.96) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL2890408 1.00 MEN1 (0.96) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL4066192 1.00 MEN1 (0.96) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL372300 1.00 MEN1 (0.96) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL2219975 1.00 MEN1 (0.96) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL413428 1.00 MEN1 (0.96) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL15535406 1.00 MEN1 (0.96) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5305358 1.00 MEN1 (0.96) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL4061743 1.00 MEN1 (0.96) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1319 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130113-A1 PIEZOELECTRIC FILMS INCLUDING IONIC LIQUIDS AND METHODS OF MAKING PIEZOELECTRIC FILMS INCLUDING IONIC LIQUIDS E INK CORP (US) 2026-05-07 — — US claimed
US-12550617-B2 Piezoelectric composite materials having improved piezoelectric properties COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2026-02-10 — — US claimed
EP-3251133-B1 WIDE OPERATING TEMPERATURE RANGE (0° TO 275°C) ULTRACAPACITOR FASTCAP ULTRACAPACITORS LLC (US) 2025-12-24 — — EP claimed
EP-4650498-A1 FLUID CONTACTING DEVICE Aurotec GmbH (AT) 2025-11-19 — — EP claimed
EP-4612118-A1 METHOD OF CONVERTING POLY(ETHYLENE TEREPHTHALATE) TO TEREPHTHALIC ACID SHPP Global Technologies B.V. (NL) 2025-09-10 — — EP claimed
EP-4614540-A2 CHIP FORM ULTRACAPACITOR FastCAP Ultracapacitors LLC (US) 2025-09-10 — — EP claimed
CN-120091990-A Process for converting poly (ethylene terephthalate) to terephthalic acid 高新特殊工程塑料全球技术有限公司 2025-06-03 — — CN claimed
EP-4094304-B1 PIEZOELECTRIC COMPOSITE MATERIALS WITH IMPROVED PIEZOELECTRIC PROPERTIES MICHELIN & CIE (FR) 2025-04-16 — — EP claimed
US-20250113829-A1 HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS nanoSUR LLC 2025-04-10 — — US claimed
EP-4526374-A1 COMPOSITIONS, RELATED SYSTEMS AND ARTICLES, AND METHODS OF MAKING AND USING THE SAME Cambridge Advanced Holdings Ltd. (KY) 2025-03-26 — — EP claimed
EP-1663921-A2 METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2006-06-07 — — EP claimed
WO-2006048171-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESELLSCHAFT (DE) 2006-05-11 — — WO claimed
EP-1649894-A2 Composition comprising electrophilic monomers and organic salts, use for treatment of keratinic materials L'OREAL (FR) 2006-04-26 — — EP claimed
WO-2006029788-A1 METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE BASF AKTIENGESELLSCHAFT (DE) 2006-03-23 — — WO claimed
WO-2006027069-A1 METHOD FOR PRODUCING HETEROCYCLIC QUATERNARY AMMONIUM AND/OR GUANIDINIUM COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2006-03-16 — — WO claimed
WO-2006027070-A1 METHOD FOR THE PRODUCTION OF HETEROCYCLIC QUATERNARY AMMONIUM COMPOUNDS AND/OR GUANIDINE COMPOUNDS HAVING HIGH PURITY BASF AKTIENGESELLSCHAFT (DE) 2006-03-16 — — WO claimed
US-20050287555-A1 Uses of cationic salts for polynucleotide synthesis AGILENT TECHNOLOGIES, INC. 2005-12-29 — — US claimed
WO-2005026089-A2 METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2005-03-24 — — WO claimed
EP-1362572-A1 Cosmetic composition comprising at least one particular organic salt and its use for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment L'OREAL (FR) 2003-11-19 — — EP claimed
EP-0693045-B1 ALKYLATION PROCESS BP CHEM INT LTD (GB) 1997-10-22 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250113829-A1 HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS NSUN2, NSUN3, RNGTT MEN1 2095/4885HSP90AA1 1395/4885KMT2A 365/4885
US-20260130113-A1 PIEZOELECTRIC FILMS INCLUDING IONIC LIQUIDS AND METHODS OF MAKING PIEZOELECTRIC FILMS INCLUDING IONIC LIQUIDS PIEZO1, MEF2D, CDH1 MEN1 670/4885HSP90AA1 4271/4885KMT2A 1595/4885
US-12550617-B2 Piezoelectric composite materials having improved piezoelectric properties PIEZO1, PIP5K1C, PIP5K1A MEN1 4192/4885HSP90AA1 1708/4885KMT2A 4331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback